890-38-0
基本信息
2ˊ-脫氧肌苷
9-(2-脫氧-Β-D-呋喃核糖基)次黃嘌呤
9-(2-DEOXY-BETA-D-RIBOFURANOSYL)HYPOXANTHINE
DEOXYINOSINE, 2'-
DI
2’-deoxy-inosin
Deoxyinosine
Hypoxanthine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-
9-(2-deoxy-β-d-ribofuranosyl)hypoxanthine
2'-Deoxy-D-inosine
9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
DEOXYINOSINE, 2'-(P)
2''-DEOXYINOSINE Crystalline
9-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydropurin-6-one
2-DEOXYINOSINE extrapure
9-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
Inosine, 2'-deoxy-
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
2024/08/19 | H52292 | 2'-脫氧肌苷, 98+% 2'-Deoxyinosine, 98+% | 890-38-0 | 250mg | 178元 |
2024/08/19 | H52292 | 2'-脫氧肌苷, 98+% 2'-Deoxyinosine, 98+% | 890-38-0 | 1g | 731元 |
2024/08/19 | H52292 | 2'-脫氧肌苷, 98+% 2'-Deoxyinosine, 98+% | 890-38-0 | 5g | 3659元 |
常見問題列表
Human Endogenous Metabolite
|
In the absence of deoxycoformycin, 2’-deoxyadenosine is primarily deaminated to 2’-deoxyinosine and then converted into hypoxanthine. In the presence of the inhibitor, the deoxynucleoside, in addition to a phosphorylation process, undergoes phosphorolytic cleavage giving rise to adenine. The conversion of 2’-deoxyadenosine to adenine might represent a protective device, emerging when the activity of adenosine deaminase is reduced or inhibited. There is much evidence to indicate that the enzyme catalyzing this processs may be distinct from methylthioadenosine phosphorylase and S-adenosyl homocysteine hydrolase, which are the enzymes reported to be responsible for the formation of adenine from 28-deoxyadenosine in mammals.